ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

December 30, 2011

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

DeVita On Problems Of Drug Response: There May be Tw Populations Of Cells; Molecular Medicine will Change Treatment

December 13, 1991